Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery. [electronic resource]
Producer: 20200928Description: 6080-6098 p. digitalISSN:- 1838-7640
- Animals
- Antineoplastic Agents, Immunological -- administration & dosage
- Breast Neoplasms -- drug therapy
- Drug Delivery Systems
- Drug Liberation
- Female
- Humans
- Hydrogels -- administration & dosage
- Injections
- Mastectomy, Segmental
- Mice
- Neoplasm Recurrence, Local -- prevention & control
- Polyesters -- administration & dosage
- Polyethylene Glycols -- administration & dosage
- Polymers -- administration & dosage
- Receptor, ErbB-2 -- antagonists & inhibitors
- Temperature
- Tissue Distribution
- Trastuzumab -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.